Irving Ariel (38 results)

Hardcover. Condition: Near Fine. 2nd Edition. Red cloth covered boards. Book pages are clean with no marks. Bookseller inventory BS/BS 12328 01/2022.

Hardcover. Condition: Fair. No Jacket. 2nd Edition. Hardcover 2nd Edition (1960), Volume 4: The Breast, Chest, and Esophagus (IV) of set Treatment of Cancer and Allied Diseases. Former library book The edges are worn. The binding is square but has a little give to it and the front hinge is cracking. The interior pages are clean and unmarked. The book will be carefully packaged for shipment for protection from the elements. USPS electronic tracking number issued free of charge. …

Hardcover. Condition: Very Good. Good +. Sixth Annual. Contemporary collection of papers by 62 contributors on cancer research and treatment advances. Excellent reference work. This is the sixth annual volume presenting the "most up to date information on progress in clinical cancer". Dust jacket intact, but with moderate soiling. Book.…

Original Cloth. Condition: Fine. Second Edition.

Cloth Bound Boards. Condition: Good. No Jacket. Second Edition. 1959 Second Edition, Volume II - Tumours of the Nervous System. Burgundy cloth with gilt titles to the spine. Condition good, corners and edges rubbed, ex library central hospital medical library with stamo to front pastedown inscription and tape marks to end-papers, other than this contents clean, many illustrations, mainly from xray photographs.…

Cloth. Condition: Very Good. Dust Jacket Condition: Very Good. Second Annual. A contemporary collection of papers by 49 contributors on cancer research and treatment advances. Excellent reference work. This is the second annual volume presenting the "most up to date information on progress in clinical cancer". Book.…

Hard Cover. Condition: Very Good. No Jacket. Second Edition. university library stamps, else generally fine copy. Size: 8vo - over 7¾" - 9¾" tall.

Condition: Very Good. 1st Edition. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good. …

Hardcover. Condition: Gut. XIII, 577 pp. No dust jacket. Name on endpaper, otherwise very well preserved copy 460 Sprache: Englisch Gewicht in Gramm: 1200.

hardcover. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority.

Hardcover. Condition: Very Good. Second Edition. Volume Three only. 781 pages, complete with 1028 illustrations. 10 1/4" x 7", maroon cloth with gilt and black stamping to the spine. The covers are just slightly rubbed with some light soiling. The contents are bright and nice. About Very Good in a soiled and edge chipped dust jacket.…

Hardcover. Condition: Very Good. Dust Jacket may NOT BE INCLUDED.CDs may be missing. SHIPS FROM MULTIPLE LOCATIONS. book.

Condition: New. In.

Condition: New. In.

Condition: New. pp. xi + 383.

Condition: New. pp. xiii + 517.

Paperback. Condition: Brand New. reprint edition. 394 pages. 9.40x6.10x0.90 inches. In Stock.

Paperback. Condition: Brand New. reprint edition. 530 pages. 10.00x7.00x1.20 inches. In Stock.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The most meaningful reward to clinicians and researchers is the absence of recurrent malignancy in their patients. While in some patients the disease will be cured by resection alone, in other similarly staged cases the disease will recur despite adequate loco regional and systemic therapies. Hence, risk assessment is a complex issue with many related or unrelated prognostic factors determining outcome. The purpose of this volume is to review some of the most relevant prognostic factors of newly diagnosed breast cancer, focusing on fea tures determining the magnitude of risk. The ultimate value of establishing the significance of each prognostic factor in a given patient will be the resulting ability to plan individu alized therapies for patients at different risk of recurrence at the time of diagnosis. To secure the maximum benefit for high-risk patients, while avoiding undue toxicity in those with low-risk lesions, a well-integrated analysis of all known prognostic factors will be essential in the early postdiagnos tic period. In addition to well-established staging criteria such as axillary nodes, tumor size, receptors, scanning and radiographic examinations, the more sophisticated labora tory techniques, as discussed by several authors herein, will playa crucial role in risk assessment. Most of them, - ploidy determination, oncogenes, tumor markers, monoclonal anti bodies, growth factors, etc. -are presently available in only a minority of treatment centers.…

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The many advances in breast cancer research, as well as the large quantity of published material, make it very difficult to gain insight into the global aspects of cancer management. To follow and understand all the new developments is becoming a major challenge. For this reason, the editors decided to bring together a group of top researchers in breast cancer to provide a comprehensive, yet readable conceptual review of the state of the art of breast cancer diagnosis and therapy. The proposal to focus the review on the quantitative assessment of the risk at diagnosis, the determination of which may permit selective therapies for individual patients, was met with enthusiastic approval, resulting in the present volume with contributions by the leading investigators in the field. While the volume relating to diagnosis, published re cently, focused on efforts leading to refinement at diagnosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua tion of the first book. A refined risk assessment at diagnosis and the application of the most suitable treatments to well selected individuals are the most important steps towards avoiding the present worrisome reality of overtreating the low risk and undertreating the high-risk patients. The first few chapters of the present volume offer an insight into the general management of early breast cancer.…

Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condition: Acceptable. Used - Acceptable. Ex-library with wear - may contain significant amounts of highlighting and underlining in pen or pencil. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.…

Condition: Fair. Acceptable condition. Hinges cracked. Volume III (Reference, Medicine) NOT AVAILABLE FOR SHIPMENT OUTSIDE OF THE UNITED STATES.

Original Cloth. Condition: Collectible; Very Good. 1st. A solid copy of the 1971 1st edition. Tight and clean and VG+. Octavo, 322 pgs. Small former owner stamp to front free endpaper.

Original Cloth. Condition: Fine. First Edition.

Condition: new. Questo è un articolo print on demand.

Condition: new. Questo è un articolo print on demand.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The most meaningful reward to clinicians and researchers is the absence of recurrent malignancy in their patients. While in some patients the disease will be cured by resection alone, in other similarly staged cases the disease will recur despite adequate loco regional and systemic therapies. Hence, risk assessment is a complex issue with many related or unrelated prognostic factors determining outcome. The purpose of this volume is to review some of the most relevant prognostic factors of newly diagnosed breast cancer, focusing on fea tures determining the magnitude of risk. The ultimate value of establishing the significance of each prognostic factor in a given patient will be the resulting ability to plan individu alized therapies for patients at different risk of recurrence at the time of diagnosis. To secure the maximum benefit for high-risk patients, while avoiding undue toxicity in those with low-risk lesions, a well-integrated analysis of all known prognostic factors will be essential in the early postdiagnos tic period. In addition to well-established staging criteria such as axillary nodes, tumor size, receptors, scanning and radiographic examinations, the more sophisticated labora tory techniques, as discussed by several authors herein, will playa crucial role in risk assessment. Most of them, - ploidy determination, oncogenes, tumor markers, monoclonal anti bodies, growth factors, etc. -are presently available in only a minority of treatment centers. 400 pp. Englisch.…

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The many advances in breast cancer research, as well as the large quantity of published material, make it very difficult to gain insight into the global aspects of cancer management. To follow and understand all the new developments is becoming a major challenge. For this reason, the editors decided to bring together a group of top researchers in breast cancer to provide a comprehensive, yet readable conceptual review of the state of the art of breast cancer diagnosis and therapy. The proposal to focus the review on the quantitative assessment of the risk at diagnosis, the determination of which may permit selective therapies for individual patients, was met with enthusiastic approval, resulting in the present volume with contributions by the leading investigators in the field. While the volume relating to diagnosis, published re cently, focused on efforts leading to refinement at diagnosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua tion of the first book. A refined risk assessment at diagnosis and the application of the most suitable treatments to well selected individuals are the most important steps towards avoiding the present worrisome reality of overtreating the low risk and undertreating the high-risk patients. The first few chapters of the present volume offer an insight into the general management of early breast cancer. 532 pp. Englisch.…